Values First Advisors’s Praxis Precision Medicines PRAX Stock Holding History

Values First Advisors’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,066	Closed	-$470K	–	168
2022 Q1	$470K	Buy	3,066 +695	+29%	+$143K	0.3%	96
2021 Q4	$701K	Buy	2,371 +606	+34%	+$178K	0.42%	77
2021 Q3	$490K	Buy	+1,765	New	+$479K	0.32%	94

Other funds holding PRAX

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VVA

Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Values First Advisors's PRAX Position: Q2 2022 in Review

Values First Advisors sold out of Praxis Precision Medicines (PRAX) in Q2 2022, closing a stake of 3,066 shares — an estimated $470K sold.

Values First Advisors first reported a position in PRAX in Q3 2021 and held it in 3 quarters. The position peaked at $701K in Q4 2021. 95 funds tracked by Wall St. Rank hold PRAX as of Q2 2022.

Values First Advisors reported no remaining Praxis Precision Medicines position as of Q2 2022 after selling out during the quarter.
Values First Advisors sold 3,066 Praxis Precision Medicines shares in Q2 2022, an estimated $470K.
Values First Advisors first reported a position in Praxis Precision Medicines in Q3 2021 and held it in 3 quarters.
Values First Advisors's Praxis Precision Medicines position peaked at $701K in Q4 2021.
95 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2022.

Based on Values First Advisors's 13F filing for Q2 2022, filed 20 Jul 2022.